Baillie Gifford & CO Medpace Holdings, Inc. Transaction History
Baillie Gifford & CO
- $128 Billion
- Q3 2025
A detailed history of Baillie Gifford & CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 584,796 shares of MEDP stock, worth $339 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
584,796
Previous 522,293
11.97%
Holding current value
$339 Million
Previous $164 Million
83.42%
% of portfolio
0.24%
Previous 0.13%
Shares
6 transactions
Others Institutions Holding MEDP
# of Institutions
683Shares Held
27MCall Options Held
53.6KPut Options Held
108K-
Black Rock Inc. New York, NY2.58MShares$1.5 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$1.39 Billion0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT946KShares$549 Million1.61% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$474 Million1.35% of portfolio
-
State Street Corp Boston, MA707KShares$410 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $18B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...